ES476077A1 - Un procedimiento para preparar derivados del acido 1,3-tia- zol-glioxilico. - Google Patents
Un procedimiento para preparar derivados del acido 1,3-tia- zol-glioxilico.Info
- Publication number
- ES476077A1 ES476077A1 ES476077A ES476077A ES476077A1 ES 476077 A1 ES476077 A1 ES 476077A1 ES 476077 A ES476077 A ES 476077A ES 476077 A ES476077 A ES 476077A ES 476077 A1 ES476077 A1 ES 476077A1
- Authority
- ES
- Spain
- Prior art keywords
- hydroxy
- cephem
- disubstituted
- processes
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/50—Nitrogen atoms bound to hetero atoms
- C07D277/52—Nitrogen atoms bound to hetero atoms to sulfur atoms, e.g. sulfonamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un procedimiento para preparar derivados del ácido 1,3-tiazol-glioxílico de la fórmula: ***1 (Ver fórmula 1) en la que R1¿ es amino protegido o alcohilamino inferior protegido, procedimiento que comprende someter un compuesto de la fórmula: ***2 (Ver fórmula 2) en la que R1¿ es como se ha definido antes y Z es carboxi protegido, a una reacción de eliminación del grupo protector del carboxi.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9425/76A GB1575803A (en) | 1976-03-09 | 1976-03-09 | 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof |
GB4114576 | 1976-10-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES476077A1 true ES476077A1 (es) | 1979-05-16 |
Family
ID=26242927
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES456625A Expired ES456625A1 (es) | 1976-03-09 | 1977-03-08 | Un procedimiento para preparar compuestos de acidos 3-cefem-4-carboxilicos 3,7-sustituidos. |
ES467635A Expired ES467635A1 (es) | 1976-03-09 | 1978-03-07 | Un procedimiento para preparar compuestos de acidos 3-cefem-4-carboxilicos 3,7-disubstituidos |
ES476076A Expired ES476076A1 (es) | 1976-03-09 | 1978-12-16 | Un procedimiento para preparar derivados de 1,3-tiazol. |
ES476077A Expired ES476077A1 (es) | 1976-03-09 | 1978-12-16 | Un procedimiento para preparar derivados del acido 1,3-tia- zol-glioxilico. |
ES476075A Expired ES476075A1 (es) | 1976-03-09 | 1978-12-16 | Un procedimiento para preparar compuestos de acidos 3-cefem-4-carboxilicos 3,7-disubstituidos. |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES456625A Expired ES456625A1 (es) | 1976-03-09 | 1977-03-08 | Un procedimiento para preparar compuestos de acidos 3-cefem-4-carboxilicos 3,7-sustituidos. |
ES467635A Expired ES467635A1 (es) | 1976-03-09 | 1978-03-07 | Un procedimiento para preparar compuestos de acidos 3-cefem-4-carboxilicos 3,7-disubstituidos |
ES476076A Expired ES476076A1 (es) | 1976-03-09 | 1978-12-16 | Un procedimiento para preparar derivados de 1,3-tiazol. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES476075A Expired ES476075A1 (es) | 1976-03-09 | 1978-12-16 | Un procedimiento para preparar compuestos de acidos 3-cefem-4-carboxilicos 3,7-disubstituidos. |
Country Status (10)
Country | Link |
---|---|
US (1) | US4560765A (es) |
AR (2) | AR218241A1 (es) |
CA (1) | CA1218054A (es) |
DE (1) | DE2760288A1 (es) |
DK (2) | DK168863B1 (es) |
ES (5) | ES456625A1 (es) |
HU (2) | HU176455B (es) |
IE (1) | IE44888B1 (es) |
MX (1) | MX4658E (es) |
SE (2) | SE437832B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL69246A (en) * | 1982-08-07 | 1986-07-31 | Tanabe Seiyaku Co | 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4093803A (en) * | 1971-05-14 | 1978-06-06 | Glaxo Laboratories Limited | 7β-[2-Etherified oximino-2-(thienyl-, furyl- or pyridylacetamido)] cephalosporins |
GB1399086A (en) * | 1971-05-14 | 1975-06-25 | Glaxo Lab Ltd | Cephalosporin compounds |
SE417968B (sv) * | 1972-10-20 | 1981-04-27 | Fujisawa Pharmaceutical Co | Forfarande for framstellning av penamderivat |
US4113940A (en) * | 1973-03-15 | 1978-09-12 | Fujisawa Pharmaceutical Co., Ltd. | 7-amino 2-lower alkyl-2 or 3-cephem-4-carboxylic acid derivatives and processes for preparation thereof |
JPS5119765A (en) * | 1974-08-09 | 1976-02-17 | Takeda Chemical Industries Ltd | Aminochiazoorujudotaino seizoho |
US4298606A (en) * | 1974-12-19 | 1981-11-03 | Takeda Chemical Industries, Ltd. | Thiazolylacetamido compounds |
DK154939C (da) * | 1974-12-19 | 1989-06-12 | Takeda Chemical Industries Ltd | Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf |
DE2760484C2 (es) * | 1976-04-14 | 1992-12-03 | Takeda Chemical Industries, Ltd., Osaka, Jp |
-
1977
- 1977-03-01 IE IE439/77A patent/IE44888B1/en not_active IP Right Cessation
- 1977-03-04 CA CA000273202A patent/CA1218054A/en not_active Expired
- 1977-03-07 SE SE7702547A patent/SE437832B/xx not_active IP Right Cessation
- 1977-03-07 AR AR266766A patent/AR218241A1/es active
- 1977-03-07 MX MX775517U patent/MX4658E/es unknown
- 1977-03-07 HU HU77FU363A patent/HU176455B/hu unknown
- 1977-03-07 HU HU77FU349A patent/HU179016B/hu not_active IP Right Cessation
- 1977-03-08 DK DK101477A patent/DK168863B1/da not_active IP Right Cessation
- 1977-03-08 ES ES456625A patent/ES456625A1/es not_active Expired
- 1977-03-09 DE DE19772760288 patent/DE2760288A1/de active Pending
-
1978
- 1978-03-07 ES ES467635A patent/ES467635A1/es not_active Expired
- 1978-03-27 AR AR271539A patent/AR222010A1/es active
- 1978-12-16 ES ES476076A patent/ES476076A1/es not_active Expired
- 1978-12-16 ES ES476077A patent/ES476077A1/es not_active Expired
- 1978-12-16 ES ES476075A patent/ES476075A1/es not_active Expired
-
1983
- 1983-04-12 SE SE8302027A patent/SE454988B/sv not_active IP Right Cessation
-
1984
- 1984-01-18 US US06/571,700 patent/US4560765A/en not_active Expired - Lifetime
-
1991
- 1991-07-25 DK DK139691A patent/DK139691A/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IE44888L (en) | 1977-09-09 |
SE437832B (sv) | 1985-03-18 |
SE8302027D0 (sv) | 1983-04-12 |
ES476076A1 (es) | 1979-05-16 |
IE44888B1 (en) | 1982-05-05 |
DE2760288A1 (es) | 1985-05-09 |
ES476075A1 (es) | 1979-05-16 |
AR222010A1 (es) | 1981-04-15 |
DK139691D0 (da) | 1991-07-25 |
SE8302027L (sv) | 1983-04-12 |
ES456625A1 (es) | 1978-07-16 |
MX4658E (es) | 1982-07-19 |
SE454988B (sv) | 1988-06-13 |
DK168863B1 (da) | 1994-06-27 |
US4560765A (en) | 1985-12-24 |
AR218241A1 (es) | 1980-05-30 |
ES467635A1 (es) | 1979-09-01 |
SE7702547L (sv) | 1977-09-10 |
DK139691A (da) | 1991-07-25 |
HU179016B (en) | 1982-08-28 |
HU176455B (en) | 1981-03-28 |
DK101477A (da) | 1977-09-10 |
CA1218054A (en) | 1987-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL64905A0 (en) | Process for the preparation of 2-penem compounds,novel 2-penem compounds produced thereby and pharmaceutical compositions containing them | |
IE45597L (en) | Cephalosporins. | |
GB9402934D0 (en) | Camptothecin derivatives and process for their preparation | |
ES8306142A1 (es) | "procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil)-bencimidazolonas sustituidas". | |
PL244232A1 (en) | Process for preparing novel derivatives of /pyridiniothiomethyl/ cephalosporins | |
DE3869173D1 (de) | Amino 5,6,7,8-tetrahydronaphtho(2,3b)furanderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
ES2001341A6 (es) | Un procedimiento de producir un derivado de acido guanidinometilbenzoico. | |
HUT72434A (en) | Novel pyridone carboxylic acid derivatives, pharmaceutical compositions containing them and processes for their production | |
GR77042B (es) | ||
ZA818934B (en) | Trisubstituted pyrimido pyrimidines,processes for their preparation,and pharmaceutical compositions thereof | |
DE3367215D1 (en) | Pyridobenzodiazepinones, process for their preparation and pharmaceutical compositions containing them | |
ES8606880A1 (es) | Un procedimiento para la preparacion de nuevos peptidos. | |
ES476076A1 (es) | Un procedimiento para preparar derivados de 1,3-tiazol. | |
ES8200113A1 (es) | Un procedimiento para la preparacion de derivados de cefalosporina. | |
ES499912A1 (es) | Procedimiento para la obtencion de derivados de amino-tia- diazolilo | |
EP0346465A4 (en) | 1-CARBOXY-1-VINYLOXYIMINOAMINOTHIAZOLE CEPHALOSPORIN DERIVATIVES AND THEIR PREPARATION PROCESS. | |
ES8206534A1 (es) | Un procedimiento para la preparacion de derivados acilicos de cefalosporina | |
ES464773A1 (es) | Procedimiento para la preparacion de 2,9-dioxatriciclo (4,3,1,03,7)decanos. | |
ES485801A1 (es) | Un procedimiento de preparacion de ciclo-1,3,2-oxazafosfo- ril-derivados | |
ES454265A1 (es) | Un procedimiento para la obtencion de nuevas cefalosporinas. | |
AU6754887A (en) | Novel pregnane derivatives, processes for their preparation and pharmaceutical compositions containing same | |
ES8105734A1 (es) | Un procedimiento para la preparacion de agentes antibacterianos beta-lactanicos. | |
CH610887A5 (en) | Process for the preparation of new 7-benzoyl-2-indolinones | |
ES8304979A1 (es) | Un procedimiento para la preparacion de un compuesto de triazafluoranteno. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19990224 |